Purchase Order 75N98C25P00106

Award Date 7/31/25
Potential Completion Date 7/30/26
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Jackson, MS 39216, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The University of Mississippi Medical Center (UMMC) was awarded a $137,299.54 firm-fixed-price purchase order contract by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to provide services in Jackson, Mississippi. This award does not have a set-aside designation. UMMC, as the prime contractor, is a U.S. state government, educational institution, and state-controlled institution of higher learning. The contract has a performance period...
This $25,000.00 firm fixed-price purchase order was awarded to the University of Mississippi Medical Center (UMMC) by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract supports platelet research for Dr. Johnson's lab, with UMMC conducting research at the Jackson Heart Study to expand platelet research in African Americans. This contract is not set aside for small businesses. UMMC is a major academic health sciences...
The University of Mississippi Medical Center (UMMC) was awarded a $1,416,241.08 firm fixed-price definitive contract (Contract #75N95019C00028) by the National Institute on Drug Abuse, a civilian agency part of the National Institutes of Health. The contract has a completion date of September 22, 2023 and does not have a set-aside designation. This award appears to be a standalone contract rather than a task order under a larger contract vehicle. UMMC, as the prime contractor, will provide...
This is a $13,020 firm-fixed-price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to the University of Massachusetts Medical School (UMMS) Grants and Contracts Administration Division. The contract is for AAV8 packaging for the PAVEGET project, which is being used for a mouse model gene therapy study. The contract does not have a set-aside designation. UMMS is a land grant university and public academic health sciences...
This is a $19,206 firm-fixed price purchase order awarded by the Office of Logistics and Acquisition Operations, part of the National Institutes of Health (NIH), to the Board of Regents of the University of Nebraska, doing business as the University of Nebraska Medical Center (UNMC). The contract is for UNMC to generate two CRISPR-EASI transgenic mice for the National Institute on Deafness and Other Communication Disorders (NIDCD). UNMC was selected on a sole-source basis as the only facility...
The U.S. Department of the Navy, Bureau of Medicine and Surgery awarded a $116,624.32 firm fixed-price delivery order contract to the University of Mississippi Medical Center (UMMC) for tuition and fees. This contract is not a set-aside and has an ultimate completion date of May 31, 2017. UMMC is a large academic medical center that has received numerous federal contract and grant awards to provide specialized medical services, conduct research, and support public health initiatives for...
This is a $300,000.00 firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to the University of Maryland, College Park (UMD) for laboratory services. The contract supports maintaining mouse colonies and inducing experimental autoimmune encephalomyelitis in the animals to model multiple sclerosis. The contract was awarded on a sole-source basis, as the VA determined UMD's Fischell Department of Bioengineering was the only responsible source able to meet...
This is a federal contract award issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to the University of Mississippi Medical Center (UMMC) for the provision of tuition and fees. The contract, valued at $91,460.88, is a firm fixed-price delivery order with a performance period ending on May 31, 2018. The contract is not set aside for any specific business type. UMMC is a major academic medical center that provides specialized medical services, conducts...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $196,360.00 firm-fixed-price purchase order to the University of Mississippi Medical Center for collection of new platelet RNA-sequencing data services. The contract has a completion date of September 5, 2024 and was awarded on September 13, 2022. The University of Mississippi Medical Center is the prime contractor and there is no set-aside designation. This award aligns...
This is a $4,520.25 firm fixed-price purchase order contract awarded by the Uniformed Services University of the Health Sciences (USUHS), a Defense agency, to The Jackson Laboratory, a nonprofit biomedical research institution. The contract is for the provision of various genetically engineered mouse models, including male B6D2F1/J, C57BL/6J, B6.129S-TNFRSF1ATM1LMX TNFRS1BTM1LMX/J, B6.129S2-TNFRSF1BTM1MWM/J, and C57BL/6-TNFRSF1ATM1LMX/J mice. These specialized research animals are likely to...

This is a $14,838 firm fixed price purchase order contract awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency, to the University of Mississippi Medical Center (UMMC). The contract is for generating a mouse model for conditional and amplified expression of a gene of interest by knocking it into a safe harbor locus. This contract does not have a set-aside designation. UMMC is a U.S. state government, educational institution, and state-controlled institution of higher learning that has an extensive portfolio of federal contracts and grants, including work with the National Institutes of Health, Department of Veterans Affairs, and Department of Defense. The contract has a period of performance through July 30, 2026.

Generated 8/3/25, 12:45 AM